Ivory Raises $1 Million for Brain Health Startup

Brain health startup Ivory has successfully raised $1 million in seed funding from a group of investors including Draper Associates, SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI. The company gained visibility after appearing on Shark Tank India last year.

Based in Mumbai, Ivory had previously secured $1 million in funding from IIM-A Ventures and Capital A in April of the prior year, as well as an additional $500K from Capital A in February 2024. The funds raised will be used to enhance the technology infrastructure, expand clinical capabilities, and improve product offerings, particularly in developing scalable and evidence-based solutions, as stated in a press release.

Founded in early 2023 by Issac John and Rahul Krishnan, Ivory is dedicated to brain health, with a focus on early detection and proactive cognitive care. The platform integrates neuroscience, neuropsychology, and data-driven approaches to assist individuals in maintaining and improving their cognitive well-being.

Innovative Cognitive Health Solutions

The company provides clinical-grade cognitive assessments and custom brain health solutions through its application, allowing users to monitor and optimise their cognitive health. A multidisciplinary clinical team, encompassing experts in neuroscience, neurology, general medicine, and neuropsychology, supports Ivory.

Tackling Gaps in India’s Healthcare System

Ivory is addressing a vital gap in India’s healthcare landscape by making cognitive screening accessible, trackable, and a fundamental part of routine preventive care. The startup is also forging partnerships within the healthcare ecosystem and recently joined forces with Metropolis Healthcare to introduce the TruHealth Mind & Body package. This innovative offering merges pathology diagnostics with neuroscience-based cognitive assessments.

Competition in the Cognitive Health Space

Ivory is positioned to compete both directly and indirectly with international platforms like Cogstate, Altoida, Pearson, BrainCheck, and Linus Health. Additionally, it faces competition from traditional methods such as pen-and-paper assessments, including MoCA, MMSE, and ACE-III.